According to a new report from Intel Market Research,  Global Toremifene Citrate market was valued at USD 120 million in 2025 and is projected to reach USD 210 million by 2034, growing at a steady CAGR of 6.1% during the forecast period (2026–2034). This growth trajectory reflects increasing demand for hormonal therapies in metastatic breast cancer treatment, coupled with expanding...